Effect of Telemedicine Education and Telemonitoring on CPAP Adherence: The Tele-OSA Randomized Trial
|
|
- Denis Lawrence
- 5 years ago
- Views:
Transcription
1 ONLINE SUPPLEMENT - PROTOCOL TITLE: Effect of Telemedicine Education and Telemonitoring on CPAP Adherence: The Tele-OSA Randomized Trial STUDY CENTER CONTACT: Kaiser Permanente, Fontana Medical Center Sleep Center 9961 Sierra Ave. Fontana, CA Telephone: Fax: Date of Protocol: October 2, 2014
2 Background Obstructive sleep apnea (OSA) is a prevalent condition which based on polysomnographic criteria affects 24% of men and 9% of women in the middle-aged population 1. Due to its high prevalence, its association with cardiovascular disease, and impact on neurocognitive function such as daytime vigilance, it carries a high healthcare burden in a given population. A recent assessment estimated that the yearly economic cost of OSA to Australia (population around 23 million) to be $21 billion 2. Thus, it is important for us to consider effective treatment not just for the individual, but cost effective management of the population. Continuous positive airway pressure (CPAP) therapy remains the gold standard treatment given its ability to provide near-complete physiologic effectiveness regardless of OSA phenotype. This therapy improves daytime vigilance and is currently the only therapy with substantial evidence suggesting improvement in cardiovascular risk. 3 The primary and well-known challenge with CPAP is the incomplete adherence of patients to this therapy (long-term CPAP compliance defined by percentage of days with at least 4 hours usage is typically reported to be around 50%.) 4,5,6 Advances in CPAP technology (such as with autocpap) have not been shown to enhance use. 7,8 Rather successfully improving CPAP use is likely through emphasizing patient education regarding the risks associated with OSA, potential benefits of therapy, teaching techniques to acclimate to CPAP, and providing a system of accountability through a follow-up process. The impact of providing a system of accountability with further education/troubleshooting was reflected in a study showing improved CPAP adherence when usage was tracked daily (through a remote wireless process) followed by a telephone encounter if a problem with CPAP use was revealed. 9 Compared to a control group (usual clinical follow-up), average CPAP use per night was higher (321 minutes versus 207 minutes; p<0.0001) 3 months after initiation of therapy. The challenge with replicating this telemedicine workflow in a real-world setting is the laborintensive nature of tracking patients on a daily basis and logistics of dispensing and retrieving wireless modems. Furthermore, patient education is very time-consuming, and the ability to provide comprehensive education without built-in efficiencies could potentially affect the financial health of the provider. With the changing landscape of healthcare reimbursement which emphasizes achieving positive clinical outcomes, discovering more automated and selfdirected methods of educating and follow-up is needed. Web-Based Education Emmi Solutions produces Web-based, simple to understand, healthcare related educational programs. These programs are interactive sessions that last about 15 minutes, educating patients on the risk of certain medical conditions or assists in preparing patients for procedures. Emmi has also produced OSA related programs: 1) OSA program this program educates patients on symptoms of OSA, provides animated videos depicting airway narrowing during OSA events, discusses health related risks of OSA such as cardiovascular disease and impact on daytime vigilance, preliminarily discusses CPAP as potential therapy, and discusses the testing process with ambulatory or in-lab polysomnography 2) CPAP program this program educates patients on how to properly use CPAP and wear the mask, discusses potential benefits of CPAP use including impact on health risks and daytime vigilance, provides methods of acclimating to CPAP, encourages patients to give a dedicated trial of CPAP even if initially having trouble, and instructs on how to care for their device and replace equipment. E2
3 Links to each of these programs are ed to the patient and date of birth needs to be verified before the program will start. The programs ask the patient for feedback at regular intervals and provide opportunities throughout to make notes or write down questions that can be later printed. These programs are already approved for clinical use within Kaiser Permanente which has a contract with the vendor. Interactive Voice Response/Automated Feedback Messaging Interactive Voice Response Interactive Voice Response (IVR) is a protocol in which automated messages are delivered to patients to provide feedback regarding their CPAP use, intended to improve therapy adherence. While IVR refers to voice calls via telephone, we use this term to also include messages that are delivered by text messaging and . The basic protocol involves the use of CPAP devices that wirelessly send usage data to a cloud platform. Automated algorithms will assess the usage data and send messages to the patient when there is suboptimal usage or to provide encouragement for successful use (See Protocol Figure 1 for programmed thresholds that will trigger a message). Specifically, the investigators will use CPAP devices with built-in modems (AirSense 10; ResMed Corp) which will send usage data via cellular network (Verizon or Sprint depending on signal availability) to cloud based platform (AirView; ResMed Corp). This data will be transferred to a second cloud-based platform (U-Sleep; Umbian), and it is this second platform that will automatically analyze the usage data and send the automated messages back to the patients. With each message, there will be a reminder to contact the sleep center for questions or problems regarding CPAP usage. Patients also have the ability to login to the U-Sleep platform at any time to track their own therapy information. Study Proposal The investigators plan to investigate the impact of adjunct web education and automated followup on CPAP use and other measurements of patient engagement. The Kaiser Permanente Fontana Sleep Disorders Center (Fontana, California) is an integrated sleep center that functions as a closed-loop system which balances diagnostic testing with a wide array of different follow-up programs. 10 The primary diagnostic pathway within our center for suspected OSA is with home sleep testing that begins with classroom education and includes setup of a home sleep testing device. Subsequent clinical visits are individual appointments, and patients undergo a 1 week autocpap trial if OSA is present. If appropriate, patients are subsequently ordered a CPAP for long-term use, and a 3 month follow-up visit is scheduled. Our study enrolls patients into one of four pathways: 1) One-fourth of our patients will follow our usual workflow that functions as our primary control group (Traditional Pathway); 2) One-fourth will follow the usual workflow with the addition of Emmi OSA education prior to the initial OSA class and Emmi CPAP education in those undergoing an autocpap trial (Telemedicine Education Pathway); 3) One-fourth will follow usual workflow with the addition of IVR follow-up (Telemedicine IVR Pathway); 4) One fourth will follow usual workflow with addition of both Emmi programs and IVR follow-up (Telemedicine Both Pathway) The specific aims of this pilot study are as follows: 1. Assess impact of Telemedicine mechanisms on CPAP use 3 months after initiating therapy in comparison to Traditional pathway patients. 2. Assess impact of Telemedicine mechanisms on functional outcomes at 3 months after initiation of therapy in comparison to Traditional pathway patients. Methods Study Design This performance improvement initiative is structured as a randomized controlled trial designed to assess impact of automated educational and follow-up mechanisms on measure of patient engagement in patients with OSA. Consecutive patients triaged to home sleep testing for E3
4 suspected OSA are scheduled to attend an OSA class (the investigators schedule 5 classes of 13 patients per week). Classes will be variably assigned to follow one of the 4 Pathways (1 Traditional and 3 Telemedicine) thus result in group randomization (classes rather than individual patients are randomized) See Protocol Figure 2. Classes will be randomized 1:1:1:1. Traditional Pathway Patients will attend a 1 hour OSA Class (class size 13) where OSA education is provided and home sleep testing (Nox T3, Carefusion) is set up. These patients return the next day for individual appointments where study is scored and test results are discussed with patient. If study is consistent with OSA based on Apnea Hypopnea Index (AHI4%) at least 5/hour, patients undergo a 1 week autocpap trial. During this week, wireless remote monitoring (AirView; ResMed) is performed and troubleshooting is provided via telephone encounter if problems with CPAP use are identified. The autocpap is returned during an individual visit, and CPAP is ordered for long-term use based on trial results and patient feedback. Patients are scheduled a 3 month follow-up appointment but are also instructed to call their sleep center case manager (or visit the walk-in clinic) prior to that visit if there are problems with CPAP use. Telemedicine Education Pathway Patients follow our usual workflow as outlined in the Traditional Pathway. In addition, patients are ed a link to view the Emmi OSA program within 2 weeks prior to their initial OSA class. If the patient tests positive for OSA and agrees to an autocpap trial, the patient is ed a link to view the Emmi CPAP program. These patients are also scheduled for a 3 month followup visit to check CPAP usage. Telemedicine IVR Pathway Patients follow our usual workflow as outlined in the Traditional Pathway. Additionally, if CPAP is ordered for long-term therapy, the patient is enrolled into an IVR protocol (U-Sleep) that automatically analyzes the patient s CPAP use. If specific provider-defined thresholds are met (Protocol Figure 1), the platform will automatically deliver feedback messages to the patient (via patient s choice of phone call, text messaging, or ) with the intention of encouraging better CPAP use. Patients are instructed to contact the sleep center for any issues with their therapy. This platform also includes a method for patients to track their own usage online. Automated messaging mechanism will be active for 3 months after CPAP is ordered, after which the messaging will stop. These patients are also scheduled for a 3 month follow-up visit. Telemedicine Both Pathway Patients follow our usual workflow as outlined in the Traditional Pathway. In addition, patients are provided both Emmi education programs and IVR follow-up as previously outlined. These patients are also scheduled for a 3 month follow-up. Measured Variables Age, gender, body mass index, polysomnography respiratory parameters, ESS (Epworth Sleepiness Scale), Functional Outcomes of Sleep Questionnaire - 10 Questions (FOSQ-10) will be assessed at baseline. CPAP use, Epworth sleepiness scale, and FOSQ-10 will be assessed at 3 month follow-up. These measured variables are already part of our standard clinical assessment. The investigators will also evaluate measures of patient engagement and costeffectiveness of care by collecting information regarding adherence and number of provider encounters. Endpoints Primary endpoint: Difference in 3 month CPAP use (hours per night) between each Telemedicine pathway compared to Traditional pathway. Secondary endpoint: E4
5 1. Difference in 3 month FOSQ-10 between the each Telemedicine pathway compared to Traditional pathway. 2. Difference in CPAP use and FOSQ-10 between each of the Telemedicine pathways. Statistical Analysis This study investigates the impact of two telemedicine mechanisms on 90 day CPAP adherence. We will analyze their impact with an intention to treat analysis. Thus, we will include patients in the educational arms in the analysis regardless of whether they view the telemedicine education program; we will also include patients in the IVR (automated feedback messaging) arms in the analysis even if they decline the opportunity to use the messaging. There are four study arms. Baseline characteristics will be compared using a one-way ANOVA test to determine whether there is a significant difference among the four arms collectively. CPAP usage and related metrics will be analyzed using mixed-effects general linear models for continuous measures and mixed-effects logistic regression for Medicare compliance rates. Treatment will be treated as a fixed effect with a one-way ANOVA parameterization (to compare the four treatments) and with a two-way ANOVA parameterization (to evaluate the effects of the Tel-Ed and Tel-TM interventions). The HSAT class the patient attends will be treated as a random effect to account for potential correlations between patients in the same class. Student s T-test will also be used to compare HSAT class attendance rates between those that receive telemedicine education versus those that do not. Means and medians of healthcare encounter rates among the four arms will be calculated and one-way ANOVA will be used to analyze if appropriate. Tukey s post-hoc adjustment and Bonferonni correction will be applied when appropriate to take into account multiple comparisons. To detect a 0.5-hour increase in average nightly CPAP usage with a standard deviation of 2.2 hours (as found in the Fox et al. study) 9 with 80% probability, it was estimated that 283 patients per group would be required at the 0.05 significance level, while 127 patients per group would detect a 0.75-hour increase with 80% probability. We aim to enroll about 127 to 250 patients per group or 508 to 1000 total with CPAP prescribed, which should allow us to draw some useful conclusions. Taking into account that about 10% of patients will be excluded from the study (e.g. for previous CPAP use), HSAT class attendance rate is about 70%, rate of OSA diagnosis in those attending and undergoing HSAT is about 80%, and about 70% of those with OSA are eventually prescribed CPAP, we anticipate that 1440 to 2835 total patients (scheduled for the HSAT class) will need to be enrolled into the study. E5
6 Protocol Figures Protocol Figure 1: Interactive Voice Response (Automated Feedback Messaging Triggers and Messages) Threshold No CPAP data for 3 consecutive days CPAP usage <4h for 3 consecutive nights CPAP usage met Medicare criteria for adherence Message Kaiser Permanente Sleep Center is notifying you that data have not been received for the previous three days. For further info call [sleep center phone number]. Kaiser Permanente is notifying you that you have missed meeting your usage target for the past 3 nights. For further info call [sleep center phone number]. Congratulations! Kaiser Permanente is notifying you that you have achieved your Sleep Therapy Adherence goal. For further info call [sleep center phone number].
7 Patient referred to Sleep Center for suspected OSA triaged to Protocol Figure 2: Traditional versus Telemedicine Pathways HST=Home Sleep Testing; FOSQ10=Functional Outcomes of Sleep Questionnaire-Short Version; Questionnaire; IVR=Interactive Voice Response (includes option for text and messaging via U-Sleep Platform; Umbian) TRADITIONAL PATHWAY TELEMEDICINE EDUCATION PATHWAY TELEMEDICINE IVR PATHWAY TELEMEDICINE BOTH PATHWAY Emmi OSA Emmi OSA OSA Class (up to 13) Sleep Questionnaire OSA Class (up to 13) Sleep Questionnaire OSA Class (up to 13) Sleep Questionnaire OSA Class (up to 13) Sleep Questionnaire Case Manager Individual Appointment HST Return Sleep Center AutoCPAP Setup Case Manager Individual Appointment HST Return Sleep Center AutoCPAP Setup Case Manager Individual Appointment HST Return Sleep Center AutoCPAP Setup Case Manager Individual Appointment HST Return Sleep Center AutoCPAP Setup Emmi CPAP Emmi CPAP Remote check by tech (AirView) Case manager individual appointment Sleep Center AutoCPAP Return Case manager individual appointment Sleep Center AutoCPAP Return Case manager individual appointment Sleep Center AutoCPAP Return Case manager individual appointment Sleep Center AutoCPAP Return IVR IVR Case Manager 3 month Follow-up CPAP compliance check ESS, FOSQ10 Case Manager 3 month Follow-up CPAP compliance check ESS, FOSQ10 Case Manager 3 month Follow-up CPAP compliance check ESS, FOSQ10 Case Manager 3 month Follow-up CPAP compliance check ESS, FOSQ10
8 Expected Results We anticipate that CPAP usage will be higher in the three Telemedicine Pathways (intervention pathways) at 3 months, and anticipate that it will be highest when both Emmi education and IVR(automated feedback messagin) are utilized. We also anticipate that the pathways that preeducate patients with the Emmi program will demonstrate a lower No show rate for the initial OSA class, higher rate of moderate/severe OSA patients agreeing to CPAP therapy, and better subjective outcomes based on sleep survey results. Significance of Research As stated in the Background section, OSA carries a significant burden on the healthcare system, thus providing effective therapy for OSA is critical for both the individual and for the population. CPAP therapy is limited by incomplete adherence to therapy, and the strategy likely most effective in improving use is with enhancing patient education and providing accountability through a follow-up system. As the healthcare system evolves, we will rely more heavily on technology to provide cost-efficient delivery of care, especially considering that patient education is a critical but very time-consuming exercise. If this study shows that a web-based education program and automated follow-up can improve CPAP use, this provides a potential process for sleep providers to adopt. Furthermore, the automated Web-based education can be particularly useful for non-sleep specialist directed care of OSA, such as primary care clinics in remote locations without proximity to a sleep center. The automated IVR/feedback messaging mechanism is potentially useful in managing other chronic sleep and non-sleep disorders. While we look forward to the continued implementation of smartphone applications and remote video encounters, we anticipate that asynchronic telemedicine mechanisms such as webeducation and automated follow-up processes will be an essential solution to the future of costeffective healthcare delivery. Citations 1 Young et al. The Occurrence of Sleep Disordered Breathing among Middle-Aged Adults. N Engl J Med 1993;328: The Economic Cost of Sleep Disorders in Australia. Sleep Health Foundation. Deloitte Access Economics Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012;8: Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993; 147: Iftikhar IH, Valentine CW, Bittencourt LR, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens 2014;32: Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ. Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat. J Clin Sleep Med 2015;11: Nolan GM, Doherty LS, Mc Nicholas WT. Auto-adjusting versus fixed positive pressure therapy in mild to moderate obstructive sleep apnoea. Sleep Feb;30(2): Ryan S, Doherty LS, Nolan GM, McNicholas WT. Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med Oct 15;5(5): Fox et al. The impact of a telemedicine monitoring system on positive airway pressure adherence in patients with obstructive sleep apnea: a randomized controlled trial. Sleep Apr 1;35(4): Hwang, Dennis. Pathway to Progress: Kaiser Permanente rethinks its sleep center delivery care model. Sleep Review Magazine. October E8
Clinical Trials in OSA
24th ANNUAL ADVANCES IN SLEEP APNEA AND SNORING February 16-17, 2018 Grand Hyatt on Union Square San Francisco, California Clinical Trials in OSA Samuel T. Kuna, MD Department of Medicine Center for Sleep
More informationThe International Palestinian Congress in Sleep Medicine
The International Palestinian Congress in Sleep Medicine Temporomandibular Disorders and Sleep Apnea 26 and 27 October, 2017 Notre Dame Hotel, Jerusalem Using PAP Downloads to Manage Sleep Apnea Patients
More informationRESEARCH PACKET DENTAL SLEEP MEDICINE
RESEARCH PACKET DENTAL SLEEP MEDICINE American Academy of Dental Sleep Medicine Dental Sleep Medicine Research Packet Page 1 Table of Contents Research: Oral Appliance Therapy vs. Continuous Positive Airway
More informationAs intuitive as it is informative
As intuitive as it is informative AirView is a cloud-based system that helps you manage sleep and respiratory patients, simplify workflows and collaborate more efficiently across the patient s care network.
More informationEffect of Telemedicine Education and Telemonitoring on CPAP Adherence: The Tele-OSA
Effect of Telemedicine Education and Telemonitoring on CPAP Adherence: The Tele-OSA Randomized Trial Short title: The Tele-OSA Randomized Clinical Trial Dennis Hwang, MD 1 ; Jeremiah W. Chang, MS 1 ; Adam
More informationEnclosed on Page 5 is an authorization form to release your health information.
Monitor Medical, Inc. "The CPAP Co." Ph: (877) 569-9436 Fax: (888) 773-2854 www.monitormedical.com Dear Medicare Beneficiary: Thank you for selecting Monitor Medical, Inc. to provide you with all of your
More informationData Management of the Sleep Disordered Breathing Patient
Data Management of the Sleep Disordered Breathing Patient 1 AARC or AAST CEU credit As Allies in Better Sleep and Breathing, we make it our #1 priority to work in harmony with caregivers and patients to
More informationTelemedicine in OSA. New Approaches to Diagnosis and Management. Katie Sarmiento, MD MPH February 16, 2018
Telemedicine in OSA New Approaches to Diagnosis and Management Katie Sarmiento, MD MPH February 16, 2018 Telemedicine Video Teleconferencing Store and Forward of data Remote monitoring of patient physiologic
More informationA new beginning in therapy for women
A new beginning in therapy for women OSA in women Tailored solutions for Her AutoSet for Her algorithm ResMed.com Women and OSA OSA has traditionally been considered to be a male disease. However, recent
More informationAn Engagement Solution You Won t Lose Sleep Over
An Engagement Solution You Won t Lose Sleep Over Providing Results & A Positive ROI How two sleep centers utilize engagement technology to prepare patients, encourage attendance & increase use of CPAP
More informationObstructive Sleep Apnea Syndrome. Common sleep disorder causes high blood pressure and heart attacks
Obstructive Sleep Apnea Syndrome Common sleep disorder causes high blood pressure and heart attacks Message: Sleep apnea is very common. It is estimated that 158 million people worldwide suffer from sleep
More informationCPAP The Treatment of Choice for Patients with OSA
CPAP The Treatment of Choice for Patients with OSA Samuel T. Kuna, M.D. Department of Medicine Center for Sleep and Respiratory Neurobiology University of Pennsylvania Pulmonary, Critical Care & Sleep
More informationDrug Prior Authorization Form Alertec (modafinil)
This document contains both information and form fields. To read information, use the Down Arrow from a form field. Drug Prior Authorization Form The purpose of this form is to obtain information required
More informationGoals Session Putting it all Together
Goals Session Putting it all Together Adherence to therapy Case presentations Treatment issues Charles Atwood, MD, FCCP, FAASM University of Pittsburgh Disclosures Advisory - Carecore National; Philips;
More informationCentral Sleep Apnoea during CPAP therapy First insights from a big data analysis. April 2018
Central Sleep Apnoea during CPAP therapy First insights from a big data analysis April 2018 Agenda Lexicon Introduction to Big Data The findings of the Trajectories of Emergent Central Sleep Apnea during
More informationUse of Technology in the Assessment of Type 2 Diabetes and Sleep Apnea
Use of Technology in the Assessment of Type 2 Diabetes and Sleep Apnea Eileen R. Chasens, PhD Associate Professor University of Pittsburgh September 3, 2014 Disclosure I do not own a Smart Phone, I have
More informationChristopher D. Turnbull 1,2, Daniel J. Bratton 3, Sonya E. Craig 1, Malcolm Kohler 3, John R. Stradling 1,2. Original Article
Original Article In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP Christopher D. Turnbull
More informationMelinda Trimble RPSGT, RST
Melinda Trimble RPSGT, RST Conflict of Interest Disclosures for Speakers I have no Conflict of Interest on this topic I would like to disclose that I do work for Philips Respironics Objectives Review how
More informationWeb-Based Home Sleep Testing
Editorial Web-Based Home Sleep Testing Authors: Matthew Tarler, Ph.D., Sarah Weimer, Craig Frederick, Michael Papsidero M.D., Hani Kayyali Abstract: Study Objective: To assess the feasibility and accuracy
More informationPositive Airway Pressure (PAP) Devices Physician Frequently Asked Questions December 2008
Positive Airway Pressure (PAP) Devices Physician Frequently Asked Questions December 2008 Based on questions received from the clinical community, the following Frequently Asked Questions will address
More informationAbout VirtuOx. Was marketed exclusively by Phillips Healthcare division, Respironics for 3 years
About VirtuOx VirtuOx, Inc. assists physicians and Durable Medical Equipment (DME)( companies diagnose respiratory diseases and qualify patients for home respiratory equipment under the guidelines of CMS
More informationRediscover dreams. Key Content. DreamStation. Sleep therapy system
Key Content DreamStation Sleep therapy system Rediscover dreams 2015 Koninklijke Philips N.V. All rights reserved. Specifications are subject to change without notice. Trademarks are the property of Koninklijke
More informationCPAP. The CPAP will be covered
CPAP CPAP Did your patient have a face to face visit with the physician prior to having a sleep study that documented (1) Sleep History and symptoms and/or (2) Epworth Scale and/or (3) Physical Examination?
More informationPhilips Respironics 1010 Murry Ridge Lane, Murrysville, PA USA. Broudy JS 10/12/15 MCI PN
2015 Koninklijke Philips N.V. All rights reserved. Specifications are subject to change without notice. Trademarks are the property of Koninklijke Philips N.V. (Royal Philips) or their respective owners.
More information3/13/2014. Home Sweet Home? New Trends in Testing for Obstructive Sleep Apnea. Disclosures. No relevant financial disclosures
2014 Big Sky Pulmonary Conference Home Sweet Home? New Trends in Testing for Obstructive Sleep Apnea Eric Olson, MD Associate Professor of Medicine Co-Director, Center for Sleep Medicine Mayo Clinic olson.eric@mayo.edu
More informationRediscover the power of sleep
Rediscover the power of sleep Patient Copy Apnea solutions for all ages Mobile Sleep Services Who We Are An experienced and well trained team of sleep care professionals consisting of Registered Sleep
More informationPositive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea
Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO;
More informationMedicare CPAP/BIPAP Coverage Criteria
Medicare CPAP/BIPAP Coverage Criteria For any item to be covered by Medicare, it must 1) be eligible for a defined Medicare benefit category, 2) be reasonable and necessary for the diagnosis or treatment
More informationYear in Review. Outline of Lecture
Year in Review Allan I. Pack, M.B.Ch.B., Ph.D. John Miclot Professor of Medicine Director, Center for Sleep and Circadian Neurobiology University of Pennsylvania Perelman School of Medicine Philadelphia,
More informationAdherence Monitoring Requirements
Cigna Sleep Management Program Adherence Monitoring Requirements ResMed Airview 1 Introduction Required Equipment All DME providers participating in the Cigna Sleep Management Program must provide customers
More informationa new beginning in managing CSA ResMed.com/AirSolutions
a new beginning in managing CSA ResMed.com/AirSolutions As your partner in patient care, ResMed gives you more clinical tools to manage patients with breathing disorders that can sometimes be challenging
More informationPositive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea
Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO
More informationTOPIC: Continuing Coverage of CPAP Machines and Supplies for the Treatment of Obstructive Sleep Apnea
These documents are not used to determine benefits or reimbursement. Please reference the appropriate certificate or contract for benefit information. BLUE CROSS BLUE SHIELD of MI MEDICAL POLICY Enterprise:
More informationEXPLORE NEW POSSIBILITIES
EXPLORE NEW POSSIBILITIES TREATING SNORING AND SLEEP APNOEA HAS CHANGED FOREVER Introducing the Oventus O 2 Vent, a custom made, comfortable oral appliance with a unique airway design for the treatment
More informationDECISION AND ORDER. After due notice, a telephone hearing was held on. , Medical Director, also testified as a witness for the MHP.
STATE OF MICHIGAN MICHIGAN ADMINISTRATIVE HEARING SYSTEM FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES P.O. Box 30763, Lansing, MI 48909 (517) 373-0722; Fax: (517) 373-4147 IN THE MATTER OF:, MAHS Docket
More informationCritical Review Form Diagnostic Test
Critical Review Form Diagnostic Test Diagnosis and Initial Management of Obstructive Sleep Apnea without Polysomnography A Randomized Validation Study Annals of Internal Medicine 2007; 146: 157-166 Objectives:
More informationQUESTIONS FOR DELIBERATION
New England Comparative Effectiveness Public Advisory Council Public Meeting Hartford, Connecticut Diagnosis and Treatment of Obstructive Sleep Apnea in Adults December 6, 2012 UPDATED: November 28, 2012
More informationCERT PAP Errors: The DME CERT Outreach and Education Task Force Responds
CERT PAP Errors: The DME CERT Outreach and Education Task Force Responds DME CERT Outreach and Education Task Force National PAP Webinar, December 17, 2014 PAP CERT Errors Medical Records: Face-to-Face
More informationInspire Therapy for Sleep Apnea
Inspire Therapy for Sleep Apnea Patient Guide Giving You the FREEDOM TO SLEEP Like Everyone Else Take Comfort. Inspire therapy can help. Inspire therapy is a breakthrough implantable treatment option for
More informationEffective Treatment for Obstructive Sleep Apnoea
Effective Treatment for Obstructive Sleep Apnoea The Series of Positive Airway Pressure devices from DeVilbiss Healthcare is designed to meet the varied needs of people suffering from Obstructive Sleep
More informationEffective Treatment for Obstructive Sleep Apnoea
Effective Treatment for Obstructive Sleep Apnoea The Series of Positive Airway Pressure devices from DeVilbiss Healthcare is designed to meet the varied needs of people suffering from Obstructive Sleep
More information2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)
2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered
More informationPatients commonly arouse from sleep and experience awake states.
Sensitive to Sleep Patients commonly arouse from sleep and experience awake states. PATIENTS are intolerant of the delivered pressure and can have difficulty returning to sleep. To aid the transition back
More informationMandibular Advancement Device vs CPAP in the Treatment of Obstructive Sleep Apnea: Are they Equally Effective in Short Term Health Outcomes?
NoSnores Mandibular Advancement Device (mouthguard) for Snoring & Sleep Apnea CLINICAL REFERENCES J Clin Sleep Med. 2013 Sep;9(9):971-2. doi: 10.5664/jcsm.3008. Mandibular Advancement Device vs CPAP in
More informationDiagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea
Original Article Diagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea Ahmad Khajeh-Mehrizi 1,2 and Omid Aminian 1 1. Occupational Sleep
More informationNasal Expiratory Positive Airway Pressure (EPAP) for the Treatment of Obstructive Sleep Apnea: A Review of Clinical Studies of Provent Therapy
Nasal Expiratory Positive Airway Pressure (EPAP) for the Treatment of Obstructive Sleep Apnea: A Review of Clinical Studies of Provent Therapy Rajiv Doshi, MD; Philip Westbrook, MD Abstract Nasal EPAP
More informationSleep Quiz & Referral Form Inside
Sleep Quiz & Referral Form Inside Rediscover the power of sleep Apnea solutions for all ages Mobile Sleep Services Who We Are An experienced and well trained team of sleep care professionals consisting
More informationPhysician Dentist Collaboration
Physician Dentist Collaboration Ronald S. Prehn, ThM, DDS Legal Perspective MD CAN LEGALLY MAKE PROPER DIAGNOSIS DDS CAN LEGALLY FABRICATE DENTAL SLEEP APPLIANCES Legal Perspective TWO PROFESSIONS WORK
More informationSleep Apnea. What is sleep apnea? How does it occur? What are the symptoms?
What is sleep apnea? Sleep Apnea Sleep apnea is a serious sleep problem. If you have it, you stop breathing for more than 10 seconds at a time many times while you sleep. Another term for this problem
More informationSimple diagnostic tools for the Screening of Sleep Apnea in subjects with high risk of cardiovascular disease
Cardiovascular diseases remain the number one cause of death worldwide Simple diagnostic tools for the Screening of Sleep Apnea in subjects with high risk of cardiovascular disease Shaoguang Huang MD Department
More informationOSA and COPD: What happens when the two OVERLAP?
2011 ISRC Seminar 1 COPD OSA OSA and COPD: What happens when the two OVERLAP? Overlap Syndrome 1 OSA and COPD: What happens when the two OVERLAP? ResMed 10 JAN Global leaders in sleep and respiratory medicine
More informationTreatment of Obstructive Sleep Apnea (OSA)
MP9239 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below None Prevea360 Health Plan Medical Policy: 1.0 A continuous positive airway
More information11/13/2017. Jeremy Tabak MD, FAASM Medical Director Baptist Hospital Sleep Lab Medical Director Baptist Sleep Lab at Galloway
Jeremy Tabak MD, FAASM Medical Director Baptist Hospital Sleep Lab Medical Director Baptist Sleep Lab at Galloway HypnoLaus study: OSA effect on mortality US Preventive Services Task Force recommendations
More informationQuestions: What tests are available to diagnose sleep disordered breathing? How do you calculate overall AHI vs obstructive AHI?
Pediatric Obstructive Sleep Apnea Case Study : Margaret-Ann Carno PhD, CPNP, D,ABSM for the Sleep Education for Pulmonary Fellows and Practitioners, SRN ATS Committee April 2014. Facilitator s guide Part
More informationManagement of OSA in the Acute Care Environment. Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018
Management of OSA in the Acute Care Environment Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018 1 Learning Objectives Upon completion, the participant should be able to: Understand pathology
More informationTHE SLEEP APNEA EPIDEMIC
THE SLEEP APNEA EPIDEMIC DIAGNOSE AND TREAT WITH SLEEP TECH IN YOUR OFFICE Integrative Healthcare Symposium February 2018, New York City Jordan Stern, MD Founder & CEO, BlueSleep Founder and CEO of BlueSleep
More informationComplete Sleep Apnea Care and Diabetes A Study on Total Cost Savings
A Study on Total Cost Savings Our Leadership In Sleep Apnea Care Nevada Sleep Diagnostics, Inc. has a fifteen year history of leadership in sleep apnea care. Nevada Sleep Diagnostics consistently raises
More informationsleepview by midmark Home Sleep Test
sleepview by midmark HST Home Sleep Test Introducing SleepView. Better for your patients, designed for your practice. Home sleep testing (HST) brings the diagnosis and management of OSA to the front lines
More informationProvider guide. DreamStation CPAP DreamStation CPAP Pro DreamStation Auto CPAP DreamStation BiPAP Pro DreamStation Auto BiPAP
Provider guide DreamStation CPAP DreamStation CPAP Pro DreamStation Auto CPAP DreamStation BiPAP Pro DreamStation Auto BiPAP IMPORTANT! Remove this guide before giving the device to the patient. Only medical
More informationInspire Therapy for Sleep Apnea
Inspire Therapy for Sleep Apnea Take Heart. If you have OSA, you re not alone. More than 18 million Americans are estimated to have Obstructive Sleep Apnea (OSA). OSA occurs when the tongue and other soft
More informationClinical Practice Guidelines for the Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Clinical Practice Guidelines for the Treatment of Adult
More informationDIGITAL AUTO-TRAK + Bi-FLEX + AUTO Bi-LEVEL THE POWER OF. Sometimes when three come together the results can be quite extraordinary. Unique even.
DIGITAL AUTO-TRAK + Bi-FLEX + AUTO Bi-LEVEL THE POWER OF 3 Sometimes when three come together the results can be quite extraordinary. Unique even. W W W. R E S P I R O N I C S. C O M THE BiPAP M SERIES
More informationItamar Medical 2016 Reimbursement Coding Guide
Itamar Medical 2016 Reimbursement Coding Guide Continuous positive airway pressure (CPAP) and associated devices for Obstructive Sleep Apnea (OSA) DISCLAIMER: The information contained in this guide is
More informationOBSTRUCTIVE SLEEP APNEA and WORK Treatment Update
OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update David Claman, MD Professor of Medicine Director, UCSF Sleep Disorders Center 415-885-7886 Disclosures: None Chronic Sleep Deprivation (0 v 4 v 6 v 8 hrs)
More information1 2 3 Based on the contents detailed below, assess the substantial equivalence to a legally marketed predicate device. In that case, the standards, et
Attachment 8 Application for Treatment Positive Airway Pressure Unit, etc. (1) Scope of application Continuous positive airway pressure units and Continuous-automated positive airway pressure units in
More information2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationWelcome to the SBSM Practice and Consultation Webinar
Welcome to the SBSM Practice and Consultation Webinar CPAP Adherence We will be joined by our Presenter: Melanie Leggett, PhD, CBSM VA Medical Center Durham, NC Our Discussant is Christi Ulmer, PhD, CBSM
More informationResScan Report Interpretation Guide. FOR CLINICAL USE ONLY V1.0 June, 2011
ResScan Report Interpretation Guide FOR CLINICAL USE ONLY V1.0 June, 2011 ResMed Software Support Hours 5:30 AM to 5:30 PM (Pacific Time) Monday Friday Phone +1 (800) 424-0737, Option 6 Email TechSupportUSA@resmed.com
More informationDental Sleep Medicine Basics
Dental Sleep Medicine Basics Written By: Patrick Tessier 2018 www.tap.wiki/ Page 1 of 8 INTRODUCTION Here are some basic aspect of Dental Sleep Medicine. This viewpoint is from an industry participant,
More informationInternational Journal of Scientific & Engineering Research Volume 9, Issue 1, January ISSN
International Journal of Scientific & Engineering Research Volume 9, Issue 1, January-2018 342 The difference of sleep quality between 2-channel ambulatory monitor and diagnostic polysomnography Tengchin
More informationHealth Provider Partnerships for OSA Management in Transportation. Paul S. Valentine Chief Executive Officer Sleep HealthCenters LLC
Health Provider Partnerships for OSA Management in Transportation Paul S. Valentine Chief Executive Officer Sleep HealthCenters LLC Sleep Apnea & Multi-Modal Transportation Conference November 2011 Programs
More informationPolicy Specific Section: October 1, 2010 January 21, 2013
Medical Policy Bi-level Positive Airway Pressure (BPAP/NPPV) Type: Medical Necessity/Not Medical Necessity Policy Specific Section: Durable Medical Equipment Original Policy Date: Effective Date: October
More informationSleep 101. Kathleen Feeney RPSGT, RST, CSE Business Development Specialist
Sleep 101 Kathleen Feeney RPSGT, RST, CSE Business Development Specialist 2016 Why is Sleep Important More than one-third of the population has trouble sleeping (Gallup) Obstructive Sleep Apnea Untreated
More informationSleep Apnea: Treatment and Research in the Veterans Health Administration
Sleep Apnea: Treatment and Research in the Veterans Health Administration Daniel J. Gottlieb, MD, MPH VA Boston Healthcare System Harvard Medical School Disorders Affecting Veterans Sleep Health PTSD insomnia,
More informationClinical Technologies
Clinical Technologies Stylish on the Outside. Smart on the Inside. UNIQUE CLINICAL TECHNOLOGIES AVAILABLE WITH F&P ICON ThermoSmart Technology for more humidity and comfort Auto-adjusting algorithm for
More informationDreamStation. Provider guide
Provider guide Accessing the Provider mode screens Accessing Provider mode unlocks settings that cannot be modified by the user. To access Provider mode: 1. ce the device is powered, press and hold both
More informationA simple solution for your complex patients
A simple solution for your complex patients The market-leading servo ventilation device System One BiPAP autosv Advanced simplifies treating complex sleep-disordered breathing patients Developed for your
More informationAutotitrating CPAP: Interpreting Studies
Autotitrating CPAP: Interpreting Studies By Dave Henry RRT DeVilbiss Healthcare Inc. 1 1 Disclaimer Appendix 3 Declaration of Vested Interest Form Name of presenter: Dave Henry RRT Name of employer: DeVilbiss
More informationIndex. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acquired central hypoventilation syndrome, NPPV in children with, 475 Acute cardiogenic pulmonary edema, PAP therapy in, 394 395 Adaptive
More informationObstructive sleep apnoea How to identify?
Obstructive sleep apnoea How to identify? Walter McNicholas MD Newman Professor in Medicine, St. Vincent s University Hospital, University College Dublin, Ireland. Potential conflict of interest None Obstructive
More informationHealthy Sleep. Frederick Tolle, M.D., dabsm Community Health Network
Healthy Sleep Frederick Tolle, M.D., dabsm Community Health Network Adults should sleep 7 or more hours per night on a regular basis to promote optimal health. Getting less than 7 hours of sleep on average
More informationKey Content. A mobile application and website to engage sleep apnea patients in PAP therapy and improve adherence to treatment.
Key Content DreamMapper White paper A mobile application and website to engage sleep apnea patients in PAP therapy and improve adherence to treatment William Hardy,* RRT Jeremy Powers,* BS Jeffrey G. Jasko,*
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Obstructive sleep apnoea How to identify? Walter McNicholas MD Newman Professor in Medicine, St. Vincent s University Hospital, University College Dublin, Ireland. Potential
More informationThe MetroHealth System. Creating the HIT Organizational Culture at MetroHealth. Creating the HIT Organizational Culture
CASE STUDY CASE STUDY The MetroHealth System Optimizing Health Information Technology to Increase Vaccination Rates The MetroHealth System in Cleveland, Ohio, was the first safety-net health care system
More informationTITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines
TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines DATE: 17 January 2014 CONTEXT AND POLICY ISSUES Obstructive sleep apnea (OSA) is a common
More informationDATE: 07 August 2012 CONTEXT AND POLICY ISSUES
TITLE: Adaptive Servo Ventilation versus Continuous or Bi-Level Positive Airway Pressure: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines DATE: 07 August 2012 CONTEXT AND POLICY
More informationTotal Sleep Solution. Growing Cardiac Sleep Health Management. Together. Health Being Made Simple
Total Sleep Solution Growing Cardiac Sleep Health Management. Together. Health Being Made Simple Total Sleep Solution Sleep Apnea Management Improves Cardiac Health and Therapy Efficacy Sleep Apnea is
More informationPositive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea
Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO;
More informationUpper Airway Stimulation for Obstructive Sleep Apnea
Upper Airway Stimulation for Obstructive Sleep Apnea Background, Mechanism and Clinical Data Overview Seth Hollen RPSGT 21 May 2016 1 Conflicts of Interest Therapy Support Specialist, Inspire Medical Systems
More informationSurgical Options for the Successful Treatment of Obstructive Sleep Apnea
Surgical Options for the Successful Treatment of Obstructive Sleep Apnea Benjamin J. Teitelbaum, MD, FACS Otolaryngology Head and Neck Surgery Saint Agnes Medical Center Fresno, California Terms Apnea
More informationNASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN CHILDREN. Dr. Nguyễn Quỳnh Anh Department of Respiration 1
1 NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN CHILDREN Dr. Nguyễn Quỳnh Anh Department of Respiration 1 CONTENTS 2 1. Preface 2. Definition 3. Etiology 4. Symptoms 5. Complications
More informationHattie Perry, RN, RPSGT Intermountain Sleep Disorder Centers
Hattie Perry, RN, RPSGT Intermountain Sleep Disorder Centers Not screened for OSA symptoms during PCP visits Not referred by PCP Patient unaware of symptoms or accepts symptoms as normal. Cost of testing
More informationTired of being tired?
Tired of being tired? Narval CC MRD ResMed.com/Narval Sleepiness and snoring are possible symptoms of sleep apnea. Did you know that one in every four adults has some form of sleep disordered-breathing
More informationProvider guide. DreamStation
Provider guide DreamStation CPAP CPAP Pro Auto CPAP BiPAP Pro Auto BiPAP IMPORTANT! Remove this guide before giving the device to the patient. Only medical professionals should adjust pressure settings.
More informationPrecision Sleep Medicine
Precision Sleep Medicine Picking Winners Improves Outcomes and Avoids Side-Effects North American Dental Sleep Medicine Conference February 17-18, 2017 Clearwater Beach, FL John E. Remmers, MD Conflict
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Continuous Positive Airway Pressure (CPAP) Treatment of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) Criteria Based Access Policy Date Adopted: 13
More informationPositive Airway Pressure Systems for Sleep Disordered Breathing
Positive Airway Pressure Systems for Sleep Disordered Breathing Lori Pickrell, RRT Account Manager Roberts Home Medical Lpickrell@robertshomemedical.com Objectives Upon completion of the session, attendees
More informationIndex SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.
549 SLEEP MEDICINE CLINICS Sleep Med Clin 1 (2007) 549 553 Note: Page numbers of article titles are in boldface type. A Abdominal motion, in assessment of sleep-related breathing disorders, 452 454 Adherence,
More informationResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference
ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference Mick Farrell CEO January 8, 2018 Safe Harbor Statement Statements contained in this presentation that are not historical facts are forwardlooking
More information